New Tests Launched in April - Insights
In April 2020, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Study Shows Drug Reduces Risk of Relapse with Neuromyelitis Optica - Insights
"This study offers hope to patients, since each attack in NMO can cause loss of visual or motor function," says Sean Pittock, M.D., a Mayo Clinic neurologist and first author.
December 2023 - Clinical Microbiology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology.
search - Mayo Clinic Laboratories
Test Catalog Search Results Search...
Elitza Theel, Ph.D., Explains New Lyme Disease Testing - Insights
Elitza Theel, Ph.D., Director of the Infectious Diseases Serology Laboratory, Co-Director of the Vector-Borne Diseases Laboratory, and Associate Professor of Laboratory Medicine and Pathology, was recently interviewed by CAP Today about new...
Hot Topic Archives - Page 2 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
ulcerative-colitis-crohn-disease-therapeutic-drug-monitoring-algorithm.pdf
No enzyme activity Thiopurine therapy contraindicated Decreased enzyme activity Reduced thiopurine dosing appropriate Normal enzyme activity Appropriate for weight-based dosing Diagnosis of ulcerative colitis (UC) or Crohn disease...
https://www.mayocliniclabs.com/test-catalog/pdf-reports.php
MCL PDF Reports Values current as of May 13, 2025 Mayo Test ID Published Name PDF 2OHGP 2-Hydroxyglutaric Aciduria Gene Panel, Varies Supplemental 3MGAP 3-Methylglutaconic Aciduria Panel, Varies Supplemental ADPKP Focused Autosomal...
New tests launched in February - Insights
In February 2022, Mayo Clinic Laboratories announced fourteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
In May and June 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.